Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients

• Pietro Ravani,

  Affiliation Department of Medicine and Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Renke Maas,

  Affiliation Institute of Clinical and Experimental Pharmacology and Toxicology, Friedrich-Alexander Universität Erlangen-Nürnberg, Nuremberg, Germany

  ⨯
• Fabio Malberti,

  Affiliation Divisione di Nefrologia, Azienda Istituti Ospitalieri di Cremona, Cremona, Italy

  ⨯
• Paola Pecchini,

  Affiliation Divisione di Nefrologia, Azienda Istituti Ospitalieri di Cremona, Cremona, Italy

  ⨯
• Maren Mieth,

  Affiliation Institute of Clinical and Experimental Pharmacology and Toxicology, Friedrich-Alexander Universität Erlangen-Nürnberg, Nuremberg, Germany

  ⨯
• Robert Quinn,

  Affiliation Department of Medicine and Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Giovanni Tripepi,

  Affiliation Divisione di Nefrologia, Ospedali Riuniti and CNR IBIM, Reggio Calabria, Italy

  ⨯
• Francesca Mallamaci,

  Affiliation Divisione di Nefrologia, Ospedali Riuniti and CNR IBIM, Reggio Calabria, Italy

  ⨯
• Carmine Zoccali

  * E-mail: carmine.zoccali@tin.it

  Affiliation Divisione di Nefrologia, Ospedali Riuniti and CNR IBIM, Reggio Calabria, Italy

  ⨯